Prognostic value of the neutrophil-to-lymphocyte ratio in patients with laryngeal squamous cell carcinoma

Head and Neck

Volumn 38, Issue , 2016, Pages E1903-E1908

  Wong, B Y Winson ^a   Stafford, Nicholas D ^b   Green, Victoria L ^c   Greenman, John ^c  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

laryngeal cancer; lymphocytes; neutrophils; prognosis; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIMODALITY CANCER THERAPY; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; SMOKING; CYTOLOGY; LARYNX TUMOR; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PROGNOSIS; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84952683885     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24346     Document Type: Conference Paper

References (38)

1. Profile of head and neck cancers in England: incidence, mortality and survival. 2010. Available at: www.ncin.org.uk/view?rid=69. Accessed September 10, 2015.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.
3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P,. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
4. Balkwill F, Mantovani A,. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
5. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-867.
6. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al., Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect-a histopathological and immunohistochemical study. BMC Cancer 2001; 1: 7.
7. Lança T, Silva-Santos B,. The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy. Oncoimmunology 2012; 1: 717-725.
8. Teramukai S, Kitano T, Kishida Y, et al., Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 2009; 45: 1950-1958.
9. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH,. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283-287.
10. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
11. Petrie HT, Klassen LW, Kay HD,. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 1985; 134: 230-234.
12. Santoni M, De Giorgi U, Iacovelli R, et al., Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. Br J Cancer 2013; 109: 1755-1759.
13. Szkandera J, Absenger G, Liegl-Atzwanger B, et al., Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer 2013; 108: 1677-1683.
14. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ,. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184.
15. Toh E, Wilson J, Sebag-Montefiore D, Botterill I,. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. Colorectal Dis 2014; 16: O90-O97.
16. Sato H, Tsubosa Y, Kawano T,. Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg 2012; 36: 617-622.
17. Ikeguchi M, Urushibara S, Shimoda R, Yamamoto M, Maeta Y, Ashida K,. Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer. World J Surg Oncol 2014; 12: 210.
18. Templeton AJ, McNamara MG, Šeruga B, et al., Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106: dju124.
19. He JR, Shen GP, Ren ZF, et al., Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 2012; 34: 1769-1776.
20. An X, Ding PR, Wang FH, Jiang WQ, Li YH,. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2011; 32: 317-324.
21. Jin Y, Ye X, He C, Zhang B, Zhang Y,. Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma. Head Neck 2015; 37: 69-75.
22. Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP,. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol 2013; 107: 493-497.
23. Perisanidis C, Kornek G, Pöschl PW, et al., High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013; 30: 334.
24. Fang HY, Huang XY, Chien HT, et al., Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Laryngoscope 2013; 123: 2690-2699.
25. Tsai YD, Wang CP, Chen CY, et al., Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 2014; 36: 947-953.
26. Rachidi S, Wallace K, Wrangle JM, Day TA, Alberg AJ, Li Z,. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck 2015. [Epub ahead of print]
27. Meniawy TM, Creaney J, Lake RA, Nowak AK,. Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma. Br J Cancer 2013; 109: 1813-1820.
28. Lee DY, Hong SW, Chang YG, Lee WY, Lee B,. Clinical significance of preoperative inflammatory parameters in gastric cancer patients. J Gastric Cancer 2013; 13: 111-116.
29. Demirtaş A, Sabur V, Akinsal EC, et al., Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy? ScientificWorldJournal 2013; 2013: 703579.
30. Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H,. The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2011; 2: 735-740.
31. Jankova L, Dent OF, Chan C, Chapuis P, Clarke SJ,. Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer. BMC Cancer 2013; 13: 442.
32. Jung MR, Park YK, Jeong O, et al., Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 2011; 104: 504-510.
33. Rashid F, Waraich N, Bhatti I, et al., A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol 2010; 8: 1.
34. Li MX, Liu XM, Zhang XF, et al., Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer 2014; 134: 2403-2413.
35. Jess T, Rungoe C, Peyrin-Biroulet L,. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10: 639-645.
36. Green VL, Michno A, Stafford ND, Greenman J,. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity. Cancer Immunol Immunother 2013; 62: 863-873.
37. Chua W, Clarke SJ, Charles KA,. Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer. Support Care Cancer 2012; 20: 1869-1874.
38. Lorente D, Mateo J, Templeton AJ, et al., Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use. Ann Oncol 2015; 26: 750-755.